Digitala Vetenskapliga Arkivet

Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Plasma cytokine levels in fibromyalgia and their response to 15 weeks of progressive resistance exercise or relaxation therapy
Vise andre og tillknytning
Rekke forfattare: 112018 (engelsk)Inngår i: Mediators of Inflammation, ISSN 0962-9351, E-ISSN 1466-1861, Vol. 2018, artikkel-id 3985154Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

The aims of this study were to compare circulating cytokines between FM and healthy controls and to investigate the effect on cytokine levels by 15 weeks of progressive resistance exercise or relaxation therapy in FM. Baseline plasma cytokine levels and clinical data were analyzed in 125 women with FM and 130 age-matched healthy women. The FM women were then randomized to progressive resistance exercise (n = 49) or relaxation (n = 43). Baseline IL-2, IL-6, TNF-α, IP-10, and eotaxin were higher in FM than in healthy controls (P < 0.041), whereas IL-1β was lower (P < 0.001). There were weak correlations between cytokine levels and clinical variables. After both interventions, IL-1ra had increased (P = 0.004), while IL-1β had increased in the relaxation group (P = 0.002). Changes of IFN-γ, IL-2, IL-4, IL-6, IL-8, and IL-17A were weakly correlated with changes of PPT, but there were no significant correlations between changes of cytokine and changes in other clinical variables. The elevated plasma levels of several cytokines supports the hypothesis that chronic systemic inflammation may underlie the pathophysiology of FM even if the relation to clinical variables was weak. However, 15 weeks of resistance exercise, as performed in this study, did not show any anti-inflammatory effect on neither FM symptoms nor clinical and functional variables. This trial is registered with ClinicalTrials.gov NCT01226784, registered October 21, 2010. The first patient was recruited October 28, 2010.

sted, utgiver, år, opplag, sider
2018. Vol. 2018, artikkel-id 3985154
HSV kategori
Identifikatorer
URN: urn:nbn:se:du-30270DOI: 10.1155/2018/3985154PubMedID: 29849487OAI: oai:DiVA.org:du-30270DiVA, id: diva2:1326627
Tilgjengelig fra: 2019-06-18 Laget: 2019-06-18 Sist oppdatert: 2019-06-18bibliografisk kontrollert

Open Access i DiVA

fulltext(1740 kB)151 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 1740 kBChecksum SHA-512
674376f43359ac9083334e53f97d18d3ea3549029172089884cb33d0daa928d9edeca104e8281c1d49a325a71e8c533ad853a7c41de85e8410e48b510333da9b
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMed

Søk i DiVA

Av forfatter/redaktør
Palstam, Annie
I samme tidsskrift
Mediators of Inflammation

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 151 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 93 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf